Last updated: May 5, 2023
Sponsor: Amsterdam UMC, location VUmc
Overall Status: Active - Recruiting
Phase
4
Condition
Hot Flash
Infertility
Hypogonadism
Treatment
Lipiodol UltraFluid
Clinical Study ID
NCT05608590
NL62838.029.18
2018.004153.24
NL7926
Ages 18-39 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Women between 18-39 years of age
- Spontaneous menstrual cycle
- Perceived low risk for tubal pathology
- Undergoing fertility work-up
Exclusion
Exclusion Criteria:
- Women with known endocrine disorders (e.g. the polycystic ovary syndrome, diabetes,hyperthyroidism and hyperprolactinemia. Except for well managed hypothyroidism withTSH between 0.3 and 2.5mIU/l)
- Ovulation disorders defined as less than eight menstrual cycles per year
- Iodine allergy
- Male subfertility defined as a post-wash total motile sperm count < 1 x10^6spermatozoa/ml
- Not willing or able to sign the consent form
Study Design
Total Participants: 554
Treatment Group(s): 1
Primary Treatment: Lipiodol UltraFluid
Phase: 4
Study Start date:
August 22, 2019
Estimated Completion Date:
January 01, 2026
Study Description
Connect with a study center
Amsterdam AMC
Amsterdam, 1081HV
NetherlandsActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.